Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

AVI's Stock Drops 32 Percent On Presented Hepatitis C Data

May 11, 2006

By Aaron Lorenzo

HHS Changing Contract With VaxGen For Anthrax Vaccine

May 11, 2006

By Aaron Lorenzo

Avicena Drug Misses Endpoint But Shows Improved Mortality

May 10, 2006

By Aaron Lorenzo

Avicena Drug Misses Endpoint But Shows Improved Mortality

May 10, 2006

By Aaron Lorenzo

Surrogate Endpoints, FDA Drugs, 'Disease Mongering'

May 8, 2006

By Anette Breindl and Aaron Lorenzo

Dacogen OK'd; May Launch Planned For MDS Treatment

May 4, 2006

By Aaron Lorenzo

Dacogen OK'd; May Launch Planned For MDS Treatment

May 4, 2006

By Aaron Lorenzo

GAO Recommends Improved Post-Approval Drug Oversight

May 2, 2006

By Aaron Lorenzo

NeoPharm Trimming Jobs To Contain Costs Going Forward

May 2, 2006

By Aaron Lorenzo

NeoPharm Trimming Jobs To Contain Costs Going Forward

May 2, 2006

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...